Mangalam Drugs & Organics Ltd

BSE: 532637

total announcements

532637.BO · 15 min delayed

BSEOthers▼ NegativeDebt Restruc.1d ago

Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default

Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.

Read more →📎 1 attachment

BSECompany UpdateResults5d ago

Mangalam Drugs & Organics Ltd

Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026

Mangalam Drugs & Organics Ltd has published un-audited financial results for the quarter ended June 30, 2026, and has also provided details of a borrower's outstanding loan and credit facilities.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change6d ago

Mangalam Drugs & Organics Ltd

Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company

Mangalam Drugs & Organics Ltd has announced the appointment of Secretarial Auditor and Statutory Auditor for a term of 5 years, subject to shareholder approval. The company has also declared unaudited financial results for the quarter ended June 30, 2026, with no modified opinions from the statutory auditors.

Read more →📎 1 attachment

BSECompany UpdateAuditor Change6d ago

Mangalam Drugs & Organics Ltd

Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.

Mangalam Drugs & Organics Ltd has announced the appointment of M/s SN. Nanda & Co, Chartered Accountants as the Statutory Auditors of the Company for a term of five consecutive years, commencing from the conclusion of the 53rd AGM till the conclusion of the 58th AGM, subject to the approval of the shareholders at the ensuing AGM.

Read more →📎 1 attachment

BSEResultResults6d ago

Mangalam Drugs & Organics Ltd

Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026

Mangalam Drugs & Organics Ltd has declared its un-audited financial results for the quarter ended June 30, 2026, with the statutory auditors not expressing any modified opinions in their limited review reports.

Read more →📎 1 attachment

BSEBoard MeetingResults6d ago

Mangalam Drugs & Organics Ltd

Outcome of Board meeting held on 12th August, 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026

Mangalam Drugs & Organics Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with the appointment of secretarial auditors and statutory auditors for a period of five consecutive years.

Read more →📎 1 attachment

BSECompany UpdateAuditor Change6 Aug 2026

Mangalam Drugs & Organics Ltd

Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR), Regulations, 2015 regarding resiagntion tendered by Ragini Chokshi & Co., Secretarial Auditor of the Company ....

Mangalam Drugs & Organics Ltd has announced the resignation of its Secretarial Auditor, Ragini Chokshi & Co., effective August 4, 2026, due to pre-occupancy with professional commitments.

Read more →📎 1 attachment

BSEBoard MeetingResults5 Aug 2026

Mangalam Drugs & Organics Ltd

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Prior Intimation ....

Mangalam Drugs & Organics Ltd has scheduled a Board Meeting on August 12th, 2026 to consider and approve un-audited financial results for the quarter ended June 30, 2026, along with the appointment of secretarial auditors and statutory auditors.

Read more →📎 1 attachment